These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 594790)

  • 1. Reconsideration of orchiectomy in the treatment of advanced prostatic carcinoma.
    Jordan WP; Blackard CE; Byar DP
    South Med J; 1977 Dec; 70(12):1411-3. PubMed ID: 594790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone therapy for prostate cancer: results of the Veterans Administration Cooperative Urological Research Group studies.
    Byar DP; Corle DK
    NCI Monogr; 1988; (7):165-70. PubMed ID: 3050535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer.
    Labrie F; Dupont A; Giguère M; Borsanyi JP; Lacourciere Y; Bélanger A; Lachance R; Emond J; Monfette G
    Prog Clin Biol Res; 1988; 260():41-62. PubMed ID: 3283766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reasons for delay of endocrine treatment in cancer of the prostate (until symptomatic metastases occur).
    Christensen MM; Aagaard J; Madsen PO
    Prog Clin Biol Res; 1990; 359():7-14; discussion 15-24. PubMed ID: 2284298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nonsteroidal effects of diethylstilbestrol: the rationale for androgen deprivation therapy without estrogen deprivation in the treatment of prostate cancer.
    Scherr DS; Pitts WR
    J Urol; 2003 Nov; 170(5):1703-8. PubMed ID: 14532759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination therapy with estrogen and UFT in newly diagnosed prostatic cancer (poorly differentiated, stage D2)].
    Kondo I; Miura T; Fujii H; Harada M; Fukushima S; Kubota Y; Hosaka M
    Hinyokika Kiyo; 1996 Mar; 42(3):201-6. PubMed ID: 8619389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined androgen blockade in the management of advanced prostate cancer: a sensible or ostensible approach.
    Ansari MS; Gupta NP; Hemal AK; Dogra PN; Seth A
    Int J Urol; 2004 Dec; 11(12):1092-6. PubMed ID: 15663681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of stage IV carcinoma of the prostate.
    Resnick MI; Grayhack JT
    Urol Clin North Am; 1975 Feb; 2(1):141-61. PubMed ID: 1093057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VACURG studies of conservative treatment.
    Byar DP
    Scand J Urol Nephrol Suppl; 1980; 55():99-102. PubMed ID: 6938045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current aspects of hormonal therapy in prostate cancer].
    Altwein JE
    Helv Chir Acta; 1981 Aug; 48(3-4):391-5. PubMed ID: 7287476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intermittent diethylstilbestrol diphosphate administration on the R3327 rat prostatic carcinoma.
    Russo P; Liguori G; Heston WD; Huryk R; Yang CR; Fair WR; Whitmore WF; Herr HW
    Cancer Res; 1987 Nov; 47(22):5967-70. PubMed ID: 3664500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prelinimary report on combination therapy for advanced prostatic cancer.
    Merrin C
    Cancer Treat Rep; 1977; 61(2):313-5. PubMed ID: 559544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term followup of a randomized study of locally advanced prostate cancer treated with combined orchiectomy and external radiotherapy versus radiotherapy alone.
    Granfors T; Modig H; Damber JE; Tomic R
    J Urol; 2006 Aug; 176(2):544-7. PubMed ID: 16813885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of metastatic prostatic cancer by orchiectomy plus Anandron versus orchiectomy plus placebo. Initial results of a randomized multicenter study].
    Knönagel H; Bolle JF; Hering F; Senn E; Hodel T; Neuenschwander H; Biedermann C
    Helv Chir Acta; 1989 Aug; 56(3):343-5. PubMed ID: 2681086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination hormone-chemotherapy versus hormone therapy alone in the initial treatment of advanced prostate carcinoma--a prospective cooperative study].
    Gorski J; Böhm WD; Illig HD; Koch R
    Urologe A; 1988 Sep; 27(5):287-90. PubMed ID: 3051628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone chemotherapy for newly diagnosed patients with metastatic prostate cancer.
    Kubota Y; Nakada T; Suzuki Y; Iizima Y; Adachi Y; Hashimoto T
    Int Urol Nephrol; 1993; 25(5):469-74. PubMed ID: 8270375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced prostatic carcinoma. Early versus late endocrine therapy.
    Kozlowski JM; Ellis WJ; Grayhack JT
    Urol Clin North Am; 1991 Feb; 18(1):15-24. PubMed ID: 1992569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical studies on endocrine therapy of prostatic carcinoma (2): Prognosis of patients with prostatic carcinoma given endocrine therapy, and analyses of causes of death and side effects of endocrine therapy].
    Kumamoto Y; Tsukamoto T; Umehara T; Shimazaki J; Fuse H; Oshima H; Takeuchi H; Yoshida O; Okada K; Saito Y
    Hinyokika Kiyo; 1990 Mar; 36(3):285-93. PubMed ID: 2191570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment and survival of patients with cancer of the prostate. The Veterans Administration Co-operative Urological Research Group.
    Surg Gynecol Obstet; 1967 May; 124(5):1011-7. PubMed ID: 6022476
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of UFT on treatment of urological cancer--effect of UFT on treatment of invasive bladder cancer and advanced prostate cancer. Ibaraki Urological Cancer Chemotherapy Study Group].
    Uchida K; Takeshima H; Kikuchi K; Shimazui T; Miyanaga N; Kawai K; Akaza H; Tsuchiya A; Noguchi R; Hattori K; Manabe F; Matsuki K; Suzuki R; Ishikawa S; Kondo F; Kobayashi T; Koiso K
    Gan To Kagaku Ryoho; 1998 Jul; 25(8):1179-87. PubMed ID: 9679581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.